4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001702626-21-000002
CEO & President acquired 11,627 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
EQUELS THOMAS K. · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-24 | Grant or award : show line 1 in the form | +11,627 | $1.29 | $14,999 | 267,426 | D |
Loading xslF345X03/primary_doc.xml…